The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy
Open accessAbstract
Gene therapy holds great potential for treating almost any disease by gene silencing, protein expression, or gene correction. To efficiently deliver the nucleic acid payload to its target tissue, the genetic material needs to be combined with a delivery platform. Lipid nanoparticles (LNPs) have proven to be excellent delivery vectors for gene therapy and are increasingly entering into routine clinical practice. Over the past two decades, the optimization of LNP formulations for nucleic acid delivery has led to a well-established body of knowledge culminating in the first-ever RNA interference therapeutic using LNP technology, i.e., Onpattro, and many more in clinical development to deliver various nucleic acid payloads. Screening a lipid library in vivo for optimal gene silencing potency in hepatocytes resulted in the identification of the Onpattro formulation. Subsequent studies discovered that the key to Onpattro’s liver tropism is its ability to form a specific “biomolecular corona”. In fact, apolipoprotein E (ApoE), among other proteins, adsorbed to the LNP surface enables specific hepatocyte targeting. This proof-of-principle example demonstrates the use of the biomolecular corona for targeting specific receptors and cells, thereby opening up the road to rationally designing LNPs. To date, however, only a few studies have explored in detail the corona of LNPs, and how to efficiently modulate the corona remains poorly understood. In this review, we summarize recent discoveries about the biomolecular corona, expanding the knowledge gained with other nanoparticles to LNPs for nucleic acid delivery. In particular, we address how particle stability, biodistribution, and targeting of LNPs can be influenced by the biological environment. Onpattro is used as a case study to describe both the successful development of an LNP formulation for gene therapy and the key influence of the biological environment. Moreover, we outline the techniques available to isolate and analyze the corona of LNPs, and we highlight their advantages and drawbacks. Finally, we discuss possible implications of the biomolecular corona for LNP delivery and we examine the potential of exploiting the corona as a targeting strategy beyond the liver to develop next-generation gene therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Analysis of nanoparticle delivery to tumours
Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Self-citationmRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Knocking down barriers: advances in siRNA delivery
Whitehead, K. A., Langer, R., & Anderson, D. G. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2742 · Cited by 3,115
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Adams, D., Gonzalez-Duarte, A., O’Riordan, W. D., Yang, C.-C., Ueda, M., Kristen, A. V., Tournev, I., Schmidt, H. H., Coelho, T., Berk, J. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716153 · Cited by 3,047
Biomolecular coronas provide the biological identity of nanosized materials
Monopoli, M. P., Åberg, C., Salvati, A., & Dawson, K. A. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.207 · Cited by 3,017
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Cheng, Q., Wei, T., Farbiak, L., Johnson, L. T., Dilliard, S. A., & Siegwart, D. J. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-0669-6 · Cited by 2,383
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Tenzer, S., Docter, D., Kuharev, J., Musyanovych, A., Fetz, V., Hecht, R., Schlenk, F., Fischer, D., Kiouptsi, K., Reinhardt, C., et al. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.181 · Cited by 2,283
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Rational design of cationic lipids for siRNA delivery
Semple, S. C., Akinc, A., Chen, J., Sandhu, A. P., Mui, B. L., Cho, C. K., Sah, D. W. Y., Stebbing, D., Crosley, E. J., Yaworski, E., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1602 · Cited by 1,822
Self-citationAggarwal, P., Hall, J. B., McLeland, C. B., Dobrovolskaia, M. A., & McNeil, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.009 · Cited by 1,791
Walkey, C. D., & Chan, W. C. W. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15233e · Cited by 1,758
The entry of nanoparticles into solid tumours
Sindhwani, S., Syed, A. M., Ngai, J., Kingston, B. R., Maiorino, L., Rothschild, J., MacMillan, P., Zhang, Y., Rajesh, N. U., Hoang, T., et al. (2020) · Nature Materials · doi:10.1038/s41563-019-0566-2 · Cited by 1,732
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akinc, A., Maier, M. A., Manoharan, M., Fitzgerald, K., Jayaraman, M., Barros, S., Ansell, S., Du, X., Hope, M. J., Madden, T. D., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0591-y · Cited by 1,636
Self-citationSARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness
Corbett, K. S., Edwards, D. K., Leist, S. R., Abiona, O. M., Boyoglu-Barnum, S., Gillespie, R. A., Himansu, S., Schäfer, A., Ziwawo, C. T., DiPiazza, A. T., et al. (2020) · Nature · doi:10.1038/s41586-020-2622-0 · Cited by 1,615
Mulligan, M. J., Lyke, K. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Raabe, V., Bailey, R., Swanson, K. A., et al. (2020) · doi:10.1101/2020.06.30.20142570 · Cited by 1,569
Schöttler, S., Becker, G., Winzen, S., Steinbach, T., Mohr, K., Landfester, K., Mailänder, V., & Wurm, F. R. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.330 · Cited by 1,272
Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms
Akinc, A., Querbes, W., De, S., Qin, J., Frank-Kamenetsky, M., Jayaprakash, K. N., Jayaraman, M., Rajeev, K. G., Cantley, W. L., Dorkin, J. R., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.85 · Cited by 1,261
Lipid Nanoparticle Systems for Enabling Gene Therapies
Cullis, P. R., & Hope, M. J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.013 · Cited by 1,208
Self-citationWhat the Cell “Sees” in Bionanoscience
Walczyk, D., Bombelli, F. B., Monopoli, M. P., Lynch, I., & Dawson, K. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910675v · Cited by 1,184
Nanoparticle colloidal stability in cell culture media and impact on cellular interactions
Moore, T. L., Rodriguez-Lorenzo, L., Hirsch, V., Balog, S., Urban, D., Jud, C., Rothen-Rutishauser, B., Lattuada, M., & Petri-Fink, A. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00487f · Cited by 1,082
Hua, S., de Matos, M. B. C., Metselaar, J. M., & Storm, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00790 · Cited by 1,048
Lesniak, A., Fenaroli, F., Monopoli, M. P., Åberg, C., Dawson, K. A., & Salvati, A. (2012) · ACS Nano · doi:10.1021/nn300223w · Cited by 1,020
Pegylation: A Novel Process for Modifying Pharmacokinetics
Harris, J. M., Martin, N. E., & Modi, M. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140070-00005 · Cited by 913
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Pardi, N., Hogan, M. J., Pelc, R. S., Muramatsu, H., Andersen, H., DeMaso, C. R., Dowd, K. A., Sutherland, L. L., Scearce, R. M., Parks, R., et al. (2017) · Nature · doi:10.1038/nature21428 · Cited by 884
Nichols, J. W., & Bae, Y. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.057 · Cited by 834
Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles
Walkey, C. D., Olsen, J. B., Song, F., Liu, R., Guo, H., Olsen, D. W. H., Cohen, Y., Emili, A., & Chan, W. C. W. (2014) · ACS Nano · doi:10.1021/nn406018q · Cited by 815
Tools for translation: non-viral materials for therapeutic mRNA delivery
Hajj, K. A., & Whitehead, K. A. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.56 · Cited by 799
Detailed Identification of Plasma Proteins Adsorbed on Copolymer Nanoparticles
Cedervall, T., Lynch, I., Foy, M., Berggård, T., Donnelly, S. C., Cagney, G., Linse, S., & Dawson, K. A. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700465 · Cited by 777
Parameters influencing the stealthiness of colloidal drug delivery systems
Vonarbourg, A., Passirani, C., Saulnier, P., & Benoit, J.-P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.039 · Cited by 740
Lynch, I., Cedervall, T., Lundqvist, M., Cabaleiro-Lago, C., Linse, S., & Dawson, K. A. (2007) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2007.04.021 · Cited by 711
Minimum information reporting in bio–nano experimental literature
Faria, M., Björnmalm, M., Thurecht, K. J., Kent, S. J., Parton, R. G., Kavallaris, M., Johnston, A. P. R., Gooding, J. J., Corrie, S. R., Boyd, B. J., et al. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0246-4 · Cited by 710
The nanoparticle biomolecule corona: lessons learned – challenge accepted?
Docter, D., Westmeier, D., Markiewicz, M., Stolte, S., Knauer, S. K., & Stauber, R. H. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00217f · Cited by 693
Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA
Belliveau, N. M., Huft, J., Lin, P. J., Chen, S., Leung, A. K., Leaver, T. J., Wild, A. W., Lee, J. B., Taylor, R. J., Tam, Y. K., et al. (2012) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2012.28 · Cited by 685
Self-citationHoang Thi, T. T., Pilkington, E. H., Nguyen, D. H., Lee, J. S., Park, K. D., & Truong, N. P. (2020) · Polymers · doi:10.3390/polym12020298 · Cited by 668
Frank-Kamenetsky, M., Grefhorst, A., Anderson, N. N., Racie, T. S., Bramlage, B., Akinc, A., Butler, D., Charisse, K., Dorkin, R., Fan, Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805434105 · Cited by 642
Protein Corona of Nanoparticles: Distinct Proteins Regulate the Cellular Uptake
Ritz, S., Schöttler, S., Kotman, N., Baier, G., Musyanovych, A., Kuharev, J., Landfester, K., Schild, H., Jahn, O., Tenzer, S., et al. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00108 · Cited by 619
Lipid nanoparticles enabling gene therapies: from concepts to clinical utility
Kulkarni, J. A., Cullis, P. R., & van der Meel, R. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0721 · Cited by 592
Self-citationGaray, R. P., El-Gewely, R., Armstrong, J. K., Garratty, G., & Richette, P. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.720969 · Cited by 587
Pozzi, D., Colapicchioni, V., Caracciolo, G., Piovesana, S., Capriotti, A. L., Palchetti, S., De Grossi, S., Riccioli, A., Amenitsch, H., & Laganà, A. (2014) · Nanoscale · doi:10.1039/c3nr05559k · Cited by 581
Recent advances in stealth coating of nanoparticle drug delivery systems
Amoozgar, Z., & Yeo, Y. (2012) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1157 · Cited by 528
Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics
Kulkarni, J. A., Witzigmann, D., Chen, S., Cullis, P. R., & van der Meel, R. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00368 · Cited by 527
Self-citationThess, A., Grund, S., Mui, B. L., Hope, M. J., Baumhof, P., Fotin-Mleczek, M., & Schlake, T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.103 · Cited by 513
Mui, B. L., Tam, Y. K., Jayaraman, M., Ansell, S. M., Du, X., Tam, Y. Y. C., Lin, P. J., Chen, S., Narayanannair, J. K., Rajeev, K. G., et al. (2013) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2013.66 · Cited by 505
Self-citationChanan-Khan, A., Szebeni, J., Savay, S., Liebes, L., Rafique, N. M., Alving, C. R., & Muggia, F. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg374 · Cited by 479
McKay, P. F., Hu, K., Blakney, A. K., Samnuan, K., Brown, J. C., Penn, R., Zhou, J., Bouton, C. R., Rogers, P., Polra, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17409-9 · Cited by 462
Chonn, A., Semple, S. C., & Cullis, P. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37026-7 · Cited by 460
Self-citationRapid, deep and precise profiling of the plasma proteome with multi-nanoparticle protein corona
Blume, J. E., Manning, W. C., Troiano, G., Hornburg, D., Figa, M., Hesterberg, L., Platt, T. L., Zhao, X., Cuaresma, R. A., Everley, P. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17033-7 · Cited by 452
Jo, D. H., Kim, J. H., Lee, T. G., & Kim, J. H. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.04.015 · Cited by 433
Szebeni, J., Muggia, F., Gabizon, A., & Barenholz, Y. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.017 · Cited by 423
Barz, M., Luxenhofer, R., Zentel, R., & Vicent, M. J. (2011) · Polymer Chemistry · doi:10.1039/c0py00406e · Cited by 418
Semple, S. C., Chonn, A., & Cullis, P. R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00128-2 · Cited by 402
Self-citationDesigning the nanoparticle–biomolecule interface for “targeting and therapeutic delivery”
Mahon, E., Salvati, A., Baldelli Bombelli, F., Lynch, I., & Dawson, K. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.009 · Cited by 385
Lipid nanoparticle technology for therapeutic gene regulation in the liver
Witzigmann, D., Kulkarni, J. A., Leung, J., Chen, S., Cullis, P. R., & van der Meel, R. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.026 · Cited by 376
Self-citationDai, Q., Walkey, C., & Chan, W. C. W. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201309464 · Cited by 371
Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA
Chen, S., Tam, Y. Y. C., Lin, P. J. C., Sung, M. M. H., Tam, Y. K., & Cullis, P. R. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.059 · Cited by 366
Self-citationMapping protein binding sites on the biomolecular corona of nanoparticles
Kelly, P. M., Åberg, C., Polo, E., O'Connell, A., Cookman, J., Fallon, J., Krpetić, Ž., & Dawson, K. A. (2015) · Nature Nanotechnology · doi:10.1038/nnano.2015.47 · Cited by 360
Gessner, A., Lieske, A., Paulke, B. R., & Müller, R. H. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00081-4 · Cited by 356
Senior, J., & Gregoriadis, G. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90455-6 · Cited by 355
Saha, K., Rahimi, M., Yazdani, M., Kim, S. T., Moyano, D. F., Hou, S., Das, R., Mout, R., Rezaee, F., Mahmoudi, M., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b00053 · Cited by 355
Pardi, N., Secreto, A. J., Shan, X., Debonera, F., Glover, J., Yi, Y., Muramatsu, H., Ni, H., Mui, B. L., Tam, Y. K., et al. (2017) · Nature Communications · doi:10.1038/ncomms14630 · Cited by 352
Stone, C. A., Liu, Y., Relling, M. V., Krantz, M. S., Pratt, A. L., Abreo, A., Hemler, J. A., & Phillips, E. J. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2018.12.003 · Cited by 351
Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics
Dahlman, J. E., Kauffman, K. J., Xing, Y., Shaw, T. E., Mir, F. F., Dlott, C. C., Langer, R., Anderson, D. G., & Wang, E. T. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620874114 · Cited by 335
Temperature: The “Ignored” Factor at the NanoBio Interface
Mahmoudi, M., Abdelmonem, A. M., Behzadi, S., Clement, J. H., Dutz, S., Ejtehadi, M. R., Hartmann, R., Kantner, K., Linne, U., Maffre, P., et al. (2013) · ACS Nano · doi:10.1021/nn305337c · Cited by 333
Sago, C. D., Lokugamage, M. P., Paunovska, K., Vanover, D. A., Monaco, C. M., Shah, N. N., Gamboa Castro, M., Anderson, S. E., Rudoltz, T. G., Lando, G. N., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811276115 · Cited by 313
Vu, V. P., Gifford, G. B., Chen, F., Benasutti, H., Wang, G., Groman, E. V., Scheinman, R., Saba, L., Moghimi, S. M., & Simberg, D. (2019) · Nature Nanotechnology · doi:10.1038/s41565-018-0344-3 · Cited by 309
Personalized protein corona on nanoparticles and its clinical implications
Corbo, C., Molinaro, R., Tabatabaei, M., Farokhzad, O. C., & Mahmoudi, M. (2017) · Biomaterials Science · doi:10.1039/c6bm00921b · Cited by 308
Personalized protein coronas: a “key” factor at the nanobiointerface
Hajipour, M. J., Laurent, S., Aghaie, A., Rezaee, F., & Mahmoudi, M. (2014) · Biomaterials Science · doi:10.1039/c4bm00131a · Cited by 307
Modi, S., & Anderson, B. D. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400154a · Cited by 307
Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles
Francia, V., Yang, K., Deville, S., Reker-Smit, C., Nelissen, I., & Salvati, A. (2019) · ACS Nano · doi:10.1021/acsnano.9b03824 · Cited by 300
Self-citationInfluence of Cholesterol on the Association of Plasma Proteins with Liposomes
Semple, S. C., Chonn, A., & Cullis, P. R. (1996) · Biochemistry · doi:10.1021/bi950414i · Cited by 291
Self-citationTime Evolution of Nanoparticle–Protein Corona in Human Plasma: Relevance for Targeted Drug Delivery
Barrán-Berdón, A. L., Pozzi, D., Caracciolo, G., Capriotti, A. L., Caruso, G., Cavaliere, C., Riccioli, A., Palchetti, S., & Laganà, A. (2013) · Langmuir · doi:10.1021/la401192x · Cited by 289
Paunovska, K., Sago, C. D., Monaco, C. M., Hudson, W. H., Castro, M. G., Rudoltz, T. G., Kalathoor, S., Vanover, D. A., Santangelo, P. J., Ahmed, R., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00432 · Cited by 277
Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
Verhoef, J. J. F., Carpenter, J. F., Anchordoquy, T. J., & Schellekens, H. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.08.015 · Cited by 267
Interplay of protein corona and immune cells controls blood residency of liposomes
Giulimondi, F., Digiacomo, L., Pozzi, D., Palchetti, S., Vulpis, E., Capriotti, A. L., Chiozzi, R. Z., Laganà, A., Amenitsch, H., Masuelli, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11642-7 · Cited by 264
An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo
Li, B., Luo, X., Deng, B., Wang, J., McComb, D. W., Shi, Y., Gaensler, K. M. L., Tan, X., Dunn, A. L., Kerlin, B. A., et al. (2015) · Nano Letters · doi:10.1021/acs.nanolett.5b03528 · Cited by 261
Secreted Biomolecules Alter the Biological Identity and Cellular Interactions of Nanoparticles
Albanese, A., Walkey, C. D., Olsen, J. B., Guo, H., Emili, A., & Chan, W. C. W. (2014) · ACS Nano · doi:10.1021/nn4061012 · Cited by 258
Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles
Lara, S., Alnasser, F., Polo, E., Garry, D., Lo Giudice, M. C., Hristov, D. R., Rocks, L., Salvati, A., Yan, Y., & Dawson, K. A. (2017) · ACS Nano · doi:10.1021/acsnano.6b07933 · Cited by 243
Sakulkhu, U., Mahmoudi, M., Maurizi, L., Salaklang, J., & Hofmann, H. (2014) · Scientific Reports · doi:10.1038/srep05020 · Cited by 237
Song, L. Y., Ahkong, Q. F., Rong, Q., Wang, Z., Ansell, S., Hope, M. J., & Mui, B. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00399-6 · Cited by 228
Evaluation of Nanoparticle Aggregation in Human Blood Serum
Rausch, K., Reuter, A., Fischer, K., & Schmidt, M. (2010) · Biomacromolecules · doi:10.1021/bm100971q · Cited by 223
Kumar, V., Qin, J., Jiang, Y., Duncan, R. G., Brigham, B., Fishman, S., Nair, J. K., Akinc, A., Barros, S. A., & Kasperkovitz, P. V. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.61 · Cited by 222
Dobrovolskaia, M. A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.056 · Cited by 221
Effect of surface properties on liposomal siRNA delivery
Xia, Y., Tian, J., & Chen, X. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.056 · Cited by 220
Hadjidemetriou, M., Al-Ahmady, Z., & Kostarelos, K. (2016) · Nanoscale · doi:10.1039/c5nr09158f · Cited by 214
Szebeni, J., Baranyi, L., Savay, S., Milosevits, J., Bunger, R., Laverman, P., Metselaar, J. M., Storm, G., Chanan-Khan, A., Liebes, L., et al. (2002) · Journal of Liposome Research · doi:10.1081/lpr-120004790 · Cited by 212
The viral protein corona directs viral pathogenesis and amyloid aggregation
Ezzat, K., Pernemalm, M., Pålsson, S., Roberts, T. C., Järver, P., Dondalska, A., Bestas, B., Sobkowiak, M. J., Levänen, B., Sköld, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10192-2 · Cited by 209
PEGylation of Nanocarrier Drug Delivery Systems: State of the Art
Howard, M. D., Jay, M., Dziubla, T. D., & Lu, X. (2008) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2008.021 · Cited by 202
Colloidal stability of polymeric nanoparticles in biological fluids
Lazzari, S., Moscatelli, D., Codari, F., Salmona, M., Morbidelli, M., & Diomede, L. (2012) · Journal of Nanoparticle Research · doi:10.1007/s11051-012-0920-7 · Cited by 191
Caracciolo, G., Cardarelli, F., Pozzi, D., Salomone, F., Maccari, G., Bardi, G., Capriotti, A. L., Cavaliere, C., Papi, M., & Laganà, A. (2013) · ACS Applied Materials & Interfaces · doi:10.1021/am404171h · Cited by 188
The nanoparticle protein corona formed in human blood or human blood fractions
Lundqvist, M., Augustsson, C., Lilja, M., Lundkvist, K., Dahlbäck, B., Linse, S., & Cedervall, T. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175871 · Cited by 186
Basha, G., Novobrantseva, T. I., Rosin, N., Tam, Y. Y. C., Hafez, I. M., Wong, M. K., Sugo, T., Ruda, V. M., Qin, J., Klebanov, B., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.190 · Cited by 181
Self-citationFusion-dependent formation of lipid nanoparticles containing macromolecular payloads
Kulkarni, J. A., Witzigmann, D., Leung, J., van der Meel, R., Zaifman, J., Darjuan, M. M., Grisch-Chan, H. M., Thöny, B., Tam, Y. Y. C., & Cullis, P. R. (2019) · Nanoscale · doi:10.1039/c9nr02004g · Cited by 161
Self-citationChen, D., Ganesh, S., Wang, W., & Amiji, M. M. (2019) · Nanoscale · doi:10.1039/c8nr09855g · Cited by 158
Schöttler, S., Klein, K., Landfester, K., & Mailänder, V. (2016) · Nanoscale · doi:10.1039/c5nr08196c · Cited by 155
An Analysis of the Binding Function and Structural Organization of the Protein Corona
Zhang, Y., Wu, J. L. Y., Lazarovits, J., & Chan, W. C. W. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c01853 · Cited by 154
Müller, K. H., Motskin, M., Philpott, A. J., Routh, A. F., Shanahan, C. M., Duer, M. J., & Skepper, J. N. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.10.041 · Cited by 152
Mirshafiee, V., Kim, R., Mahmoudi, M., & Kraft, M. L. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.11.019 · Cited by 152
Personalized liposome–protein corona in the blood of breast, gastric and pancreatic cancer patients
Colapicchioni, V., Tilio, M., Digiacomo, L., Gambini, V., Palchetti, S., Marchini, C., Pozzi, D., Occhipinti, S., Amici, A. R. D., & Caracciolo, G. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.09.002 · Cited by 148
Francia, V., Montizaan, D., & Salvati, A. L. (2020) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.11.25 · Cited by 142
Self-citationChen, D., Parayath, N. N., Ganesh, S., Wang, W., & Amiji, M. M. (2019) · Nanoscale · doi:10.1039/c9nr05788a · Cited by 141
Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo
Zhu, X., Tao, W., Liu, D. X., Wu, J., Guo, Z., Ji, X., Bharwani, Z., Zhao, L., Zhao, X., Farokhzad, O. C., et al. (2017) · Theranostics · doi:10.7150/thno.18136 · Cited by 139
The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouse
Yan, X., Kuipers, F., Havekes, L. M., Havinga, R., Dontje, B., Poelstra, K., Scherphof, G. L., & Kamps, J. A. A. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.137 · Cited by 138
Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomes
Qi, X., Zhao, Z., & zhuang, Z. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s25399 · Cited by 137
A Perspective on Extracellular Vesicles Proteomics
Rosa-Fernandes, L., Bombarda-Rocha, V., Carregari, V. C., Urbani, A., & Palmisano, G. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00102 · Cited by 135
Han, X., Corson, N., Wade-Mercer, P., Gelein, R. M., Jiang, J., Sahu, M., Biswas, P., Finkelstein, J. N., Elder, A. C. P., & Oberdörster, G. (2012) · Toxicology · doi:10.1016/j.tox.2012.03.006 · Cited by 125
Bouchaala, R., Mercier, L., Andreiuk, B., Mély, Y., Vandamme, T., Anton, N., Goetz, J. G., & Klymchenko, A. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.027 · Cited by 123
Halamoda‐Kenzaoui, B., Ceridono, M., Urbán, P., Bogni, A., Ponti, J., Gioria, S., & Kinsner‐Ovaskainen, A. (2017) · Journal of Nanobiotechnology · doi:10.1186/s12951-017-0281-6 · Cited by 123
Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
Neun, B. W., Barenholz, Y., Szebeni, J., & Dobrovolskaia, M. A. (2018) · Molecules · doi:10.3390/molecules23071700 · Cited by 122
Sato, Y., Kinami, Y., Hashiba, K., & Harashima, H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.006 · Cited by 119
Evolution of the Protein Corona of Lipid Gene Vectors as a Function of Plasma Concentration
Caracciolo, G., Pozzi, D., Capriotti, A. L., Cavaliere, C., Foglia, P., Amenitsch, H. W., & Laganà, A. (2011) · Langmuir · doi:10.1021/la202912f · Cited by 109
Structural Changes in Apolipoproteins Bound to Nanoparticles
Cukalevski, R., Lundqvist, M., Oslakovic, C., Dahlbäck, B., Linse, S. S., & Cedervall, T. (2011) · Langmuir · doi:10.1021/la203290a · Cited by 107
Isolation methods for particle protein corona complexes from protein-rich matrices
Böhmert, L., Voß, L., Stock, V., Braeuning, A., Lampen, A., & Sieg, H. (2020) · Nanoscale Advances · doi:10.1039/c9na00537d · Cited by 106
Protein Adsorption: A Feasible Method for Nanoparticle Functionalization?
Cagliani, R., Gatto, F., & Bardi, G. (2019) · Materials · doi:10.3390/ma12121991 · Cited by 105
Chetwynd, A. J., Wheeler, K. E., & Lynch, I. (2019) · Nano Today · doi:10.1016/j.nantod.2019.06.004 · Cited by 101
La-Beck, N. M., & Gabizón, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00416 · Cited by 99
Sieber, S., Grossen, P., Detampel, P., Siegfried, S., Witzigmann, D., & Huwyler, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.023 · Cited by 99
Self-citationNanoparticles-cell association predicted by protein corona fingerprints
Palchetti, S., Digiacomo, L., Pozzi, D., Peruzzi, G., Micarelli, E., Mahmoudi, M., & Caracciolo, G. (2016) · Nanoscale · doi:10.1039/c6nr03898k · Cited by 93
Poly(Sarcosine) Surface Modification Imparts Stealth‐Like Properties to Liposomes
Bleher, S., Buck, J., Muhl, C., Sieber, S., Barnert, S., Witzigmann, D., Huwyler, J., Barz, M., & Süss, R. (2019) · Small · doi:10.1002/smll.201904716 · Cited by 91
Self-citationHayashi, Y., Takamiya, M., Jensen, P. B., Ojea‐Jiménez, I., Claude, H., Antony, C., Kjær-Sørensen, K., Grabher, C., Boesen, T. P., Gilliland, D. D., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b07233 · Cited by 90
In vivo protein corona patterns of lipid nanoparticles
Amici, A. R. D., Caracciolo, G., Digiacomo, L., Gambini, V., Marchini, C., Tilio, M., Capriotti, A. L., Colapicchioni, V., Matassa, R., Familiari, G., et al. (2017) · RSC Advances · doi:10.1039/c6ra25493d · Cited by 89
Abstiens, K., Figueroa, S. M., Gregoritza, M., & Göpferich, A. M. (2018) · Soft Matter · doi:10.1039/c8sm02189a · Cited by 88
Tuning liposome composition to modulate corona formation in human serum and cellular uptake
Yang, K., Mesquita, B. S., Horvatovich, P. L., & Salvati, A. L. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.02.018 · Cited by 84
Malcolm, D. W., Varghese, J. J., Sorrells, J. E., Ovitt, C. E., & Benoit, D. S. W. (2017) · ACS Nano · doi:10.1021/acsnano.7b05528 · Cited by 80
Unbiased Identification of the Liposome Protein Corona using Photoaffinity-based Chemoproteomics
Pattipeiluhu, R., Crielaard, S., Klein-Schiphorst, I., Florea, B. I., Kros, A., & Campbell, F. (2020) · ACS Central Science · doi:10.1021/acscentsci.9b01222 · Cited by 78
Determination of Plasma Protein Adsorption on Magnetic Iron Oxides: Sample Preparation
Thode, K., Lück, M., Semmler, W., Müller, R. H., & Kresse, M. (1997) · Pharmaceutical Research · doi:10.1023/a:1012104017761 · Cited by 74
Methods of protein corona isolation for magnetic nanoparticles
Bonvin, D., Chiappe, D., Moniatte, M., Hofmann, H., & Ebersold, M. M. (2017) · The Analyst · doi:10.1039/c7an00646b · Cited by 59
Palchetti, S., Caputo, D. D., Digiacomo, L., Capriotti, A. L., Coppola, R., Pozzi, D., & Caracciolo, G. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11010031 · Cited by 57
Sato, Y., Okabe, N., Note, Y., Hashiba, K., Maeki, M., Tokeshi, M., & Harashima, H. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.11.022 · Cited by 57
Pisani, C., Gaillard, J., Dorandeu, C., Charnay, C., Guari≠, Y., Chopineau, J., Devoisselle, J., Armengaud, J., & Prat, O. (2017) · Nanoscale · doi:10.1039/c7nr01654a · Cited by 43
Sakurai, Y., Mizumura, W., Ito, K., Iwasaki, K., Katoh, T., Goto, Y., Suga, H., & Harashima, H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00087 · Cited by 39
Witzigmann, D., Uhl, P., Sieber, S., Kaufman, C., Einfalt, T., Schöneweis, K., Grossen, P., Buck, J., Ni, Y., Schenk, S., et al. (2019) · eLife · doi:10.7554/elife.42276 · Cited by 34
Self-citationLi, Z., Zhu, J., Wang, Y., Zhou, M. L., Li, D., Zheng, S., Yin, L., Luo, C., Zhang, H., Zhong, L., et al. (2019) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.05.002 · Cited by 34
Tietjen, G. T., & Saltzman, W. M. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad6645 · Cited by 31
Breitner, E. K., Hussain, S. M., & Comfort, K. K. (2015) · Journal of Nanobiotechnology · doi:10.1186/s12951-015-0117-1 · Cited by 27
Sobczynski, D. J., & Eniola‐Adefeso, O. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.10.023 · Cited by 26
Dissecting the proteome of lipoproteins: New biomarkers for cardiovascular diseases?
von Zychlinski, A., & Kleffmann, T. (2015) · Translational Proteomics · doi:10.1016/j.trprot.2014.12.001 · Cited by 25
COMPARISONS OF NANOPARTICLE PROTEIN CORONA COMPLEXES ISOLATED WITH DIFFERENT METHODS
Monopoli, M. P., Wan, S., Bombelli, F. B., Mahon, E., & Dawson, K. A. (2013) · Nano LIFE · doi:10.1142/s1793984413430046 · Cited by 21
Quantifying Release from Lipid Nanocarriers by Fluorescence Correlation Spectroscopy
Bouchaala, R., Richert, L., Anton, N., Vandamme, T., Smail, D., Mély, Y., & Klymchenko, A. S. (2018) · ACS Omega · doi:10.1021/acsomega.8b01488 · Cited by 21
Morita, S., Sakurai, A., Nakano, M., Kitagawa, S., & Handa, T. (2010) · Lipids · doi:10.1007/s11745-010-3498-9 · Cited by 19
Aggregation Behavior of Nanoparticle-Peptide Systems Affects Autophagy
Legaspi, S. M., & Segatori, L. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00266 · Cited by 18
Zhou, M., Tang, M., Li, S., Li, P., Huang, H., Fang, Q., Liu, Z., Xie, P., Li, G., & Zhou, J. (2018) · Nanoscale · doi:10.1039/c8nr01077c · Cited by 12
Pun, S. H., & Hoffman, A. S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-08-087780-8.00096-6 · Cited by 9
Cited by
The role of lipid components in lipid nanoparticles for vaccines and gene therapy
Hald Albertsen, C., Kulkarni, J. A., Witzigmann, D., Lind, M., Petersson, K., & Simonsen, J. B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114416 · Cited by 1,185
Self-citationChemistry of Lipid Nanoparticles for RNA Delivery
Eygeris, Y., Gupta, M., Kim, J., & Sahay, G. (2022) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00544 · Cited by 873
Kim, J., Eygeris, Y., Gupta, M., & Sahay, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.014 · Cited by 514
Innate immune mechanisms of mRNA vaccines
Verbeke, R., Hogan, M. J., Loré, K., & Pardi, N. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.014 · Cited by 501
Lee, Y., Jeong, M., Park, J., Jung, H., & Lee, H. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01086-x · Cited by 450
Metadata
- Authors
- Francia, V., Schiffelers, R. M., Cullis, P. R., & Witzigmann, D.
- Venue
- Bioconjugate Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-08-07
- Volume
- 31
- Issue
- 9
- Pages
- 2046-2059
- ISSN
- 1043-1802 (ISSN-L)
- 1520-4812
- OpenAlex
- W3047744822
- Cited by
- 299
- References
- 149
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.